Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,500 shares at $44.25 ($155K) on 2016-01-11, disclosed to the SEC on 2016-01-13.
Open-market sale of $155k NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.25 | 1,750 | $77K | 50.0% |
| 2 | $44.25 | 1,750 | $77K | 50.0% |
| Total | $44.25 avg | 3,500 | $155K | 100% |
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |